Lobe Sciences (XCNQ:LOBE) Operating Cash Flow per Share : C$-0.00 (TTM As of Feb. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences Operating Cash Flow per Share?

Lobe Sciences's operating cash flow per share for the three months ended in Feb. 2024 was C$0.00. Lobe Sciences's operating cash flow per share for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 45.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 19.10% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Lobe Sciences's Operating Cash Flow per Share or its related term are showing as below:

XCNQ:LOBE' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -62.3 Med: 23.9 Max: 45.2
Current: 45.2

During the past 13 years, Lobe Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 45.20% per year. The lowest was -62.30% per year. And the median was 23.90% per year.

XCNQ:LOBE's 3-Year OCF Growth Rate is ranked better than
89% of 1236 companies
in the Biotechnology industry
Industry Median: 3.35 vs XCNQ:LOBE: 45.20

Lobe Sciences Operating Cash Flow per Share Historical Data

The historical data trend for Lobe Sciences's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Operating Cash Flow per Share Chart

Lobe Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.26

-0.10

-0.15

-0.07

-0.02

Lobe Sciences Quarterly Data
	Dec18	Mar19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.02	-0.01	-	-	-

Competitive Comparison of Lobe Sciences's Operating Cash Flow per Share

For the Biotechnology subindustry, Lobe Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lobe Sciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's Price-to-Operating-Cash-Flow falls into.

Lobe Sciences Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Lobe Sciences's Operating Cash Flow per Share for the fiscal year that ended in Aug. 2023 is calculated as

Operating Cash Flow per Share (A: Aug. 2023 )	=	Cash Flow from Operations (A: Aug. 2023 )	/	Shares Outstanding (Diluted Average) (A: Aug. 2023 )
	=	-1.719	/	104.351
	=	-0.02

Lobe Sciences's Operating Cash Flow per Share for the quarter that ended in Aug. 2023 is calculated as

Operating Cash Flow per Share (Q: Feb. 2024 )	=	Cash Flow from Operations (Q: Feb. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Feb. 2024 )
	=	-0.031	/	79.136
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00

Lobe Sciences Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences (XCNQ:LOBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

LOBEF:USA 6YX0:Germany

Address

1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Lobe Sciences (XCNQ:LOBE) Headlines

No Headlines